The Asian Pacific Journal of Tropical Biomedicine, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing research in the fields of tropical biomedicine. Launched in 2011 and fully embracing the open-access model since 2014, this journal has become an invaluable resource for researchers, professionals, and students alike. With an impact factor reflective of its Q3 ranking in the category of Biochemistry, Genetics and Molecular Biology (miscellaneous), it currently holds a Scopus rank of #49 out of 103, placing it in the 52nd percentile in its field. Covering diverse topics on biomedicine, the journal aims to disseminate significant findings and foster collaborative research initiatives across the Asian Pacific region and beyond. With its robust commitment to accessibility and quality, the Asian Pacific Journal of Tropical Biomedicine is a vital platform for promoting scientific knowledge and innovation.

REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO is a prestigious open-access journal that has been publishing significant research in the field of tropical medicine since its inception in 1961. Produced by the Instituto de Medicina Tropical de São Paulo, the journal boasts a commendable Q3 ranking in both the categories of Infectious Diseases and Medicine (miscellaneous), as per the latest 2023 metrics. With an ISSN of 0036-4665 and E-ISSN of 1678-9946, it serves as a prominent platform for scholars and professionals to disseminate their findings and insights on pressing health issues prevalent in tropical regions, particularly those relevant to Brazil and beyond. This journal is essential for researchers and practitioners who seek to advance their understanding and apply innovative solutions in tropical medicine, thus addressing the distinct challenges posed by infectious diseases in diverse populations. The journal is accessible through various open access platforms, ensuring that critical research is available to a global audience, fostering knowledge sharing and collaboration.

Vaccines, published by MDPI in Switzerland, is a leading open access journal that has been at the forefront of vaccine research since its inception in 2013. With an impressive impact factor and consistently ranked in the Q1 and Q2 quartiles across leading categories such as Drug Discovery, Immunology, Infectious Diseases, and Pharmacology, it provides a vital platform for researchers to share their findings and advance the field. The journal is dedicated to delivering high-quality original research articles, reviews, and case studies that address the challenges and innovations in vaccine development and immunization strategies worldwide. Open access since its launch, Vaccines ensures that cutting-edge research is widely available to the global academic community and public health professionals, thereby fostering collaboration and enhancing knowledge in this critical area of public health.

Current Tropical Medicine Reports, published by Springer, is an esteemed journal that serves as a pivotal platform for researchers, professionals, and students in the fields of immunology, allergy, and infectious diseases. With a strong focus on emerging tropical medicine topics, the journal provides an authoritative avenue for disseminating innovative research and practical insights, showcasing its commitment to advancing global health knowledge. Now in its convergence years from 2014 to 2024, it has successfully established itself in the academic community, evidenced by its Q2 rankings in the categories of Infectious Diseases and Immunology and Allergy in 2023, reflecting its impact and relevance. The journal boasts impressive Scopus rankings, holding the 50th position in Infectious Diseases and 55th in Immunology and Allergy, further underscoring its significance in these critical fields. While it operates under a subscription model, the journal serves not only as a resource for published research but also as a catalyst for collaboration and knowledge exchange among the scientific community. With a growing readership, Current Tropical Medicine Reports is poised to continue shaping the discourse surrounding tropical health challenges.

Vaccine: X, published by Elsevier, is a premier open access journal dedicated to advancing research in the interdisciplinary fields of immunology and microbiology, infectious diseases, molecular medicine, and public health. With an ISSN of 2590-1362 and operating since 2019, the journal has rapidly established an influential role, achieving Q2 rankings in major categories such as Immunology and Microbiology, Infectious Diseases, and Public Health for 2023. Its commitment to disseminating cutting-edge research is evident from its broad scope, focusing on innovative vaccines and therapies that are critical for global health. Researchers and professionals will find value in the accessible nature of the journal, which has been recognized for its contributions to veterinary medicine as well, with a Q1 ranking in the miscellaneous veterinary category. The journal proudly showcases high-quality, peer-reviewed articles and welcomes submissions that push the boundaries of current knowledge, making it an essential resource for anyone involved in vaccine research and development.

npj Vaccines, published by NATURE PORTFOLIO, is an esteemed Open Access journal that has been at the forefront of vaccination research since its inception in 2016. With an impressive impact factor and ranking in the top quartile (Q1) across several categories including Immunology, Infectious Diseases, and Pharmacology, this journal provides a crucial platform for the dissemination of high-quality research and innovative findings in the field of vaccine development. Based in the United Kingdom, and with its broad scope encompassing both fundamental and translational studies, npj Vaccines facilitates significant discourse among researchers, professionals, and students dedicated to immunization strategies and public health. The journal's commitment to Open Access ensures that vital knowledge is shared widely, promoting collaboration and advancement in vaccine science on a global scale. Scholars are encouraged to contribute to this essential field, as their findings may significantly impact the future of disease prevention and control.

The American Journal of Tropical Medicine and Hygiene, published by the American Society of Tropical Medicine & Hygiene, serves as a pivotal platform for the dissemination of innovative research and clinical findings in the realm of tropical medicine and health. With an illustrious history dating back to 1945, this journal has maintained its commitment to enhancing global health, particularly in the fields of Infectious Diseases, Parasitology, and Virology. It currently boasts an impressive impact factor and ranks in the Q1 category for Parasitology and Q2 for Infectious Diseases and Medicine (miscellaneous), highlighting its academic prominence. The journal's mission is to advance research, showcase cutting-edge studies, and foster collaboration among researchers, healthcare professionals, and students dedicated to tackling tropical diseases and improving public health worldwide. While access is not open, the journal remains a critical resource for anyone looking to stay informed on the latest advancements in the field.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

JOURNAL OF TROPICAL PEDIATRICS, published by Oxford University Press, stands as a critical platform for the dissemination of research and clinical advancements in the field of tropical pediatrics. With a rich history dating back to 1955, this journal serves as a significant contributor to our understanding of health issues affecting children in tropical and subtropical regions, focusing on infectious diseases, pediatric care, and child health. It currently holds an impressive Q2 ranking in three categories: Infectious Diseases, Medicine (miscellaneous), and Pediatrics, Perinatology and Child Health, placing it among the top journals in its field. Featuring both formative research and applied studies, the journal aims to address the unique challenges posed by pediatric care in tropical environments. Its inclusion in an esteemed database ensures a broad dissemination of critical knowledge to researchers, healthcare professionals, and students alike, promoting a collaborative approach to improving child health outcomes globally.

Expert Review of Vaccines, published by Taylor & Francis Ltd, is a pivotal open access journal that has established itself as a leading source of peer-reviewed articles focusing on vaccine research, development, and policy. With an impressive categorization in the top quartile (Q1) across various domains including Drug Discovery, Immunology, Molecular Medicine, and Pharmacology for 2023, this journal plays a crucial role in disseminating high-quality scientific findings that drive advances in the field. Located in the United Kingdom, it serves a global audience of researchers, healthcare professionals, and students seeking to stay abreast of cutting-edge developments in vaccination strategies and technologies. The journal’s Scopus ranks further attest to its excellence, boasting remarkable placements in Pharmacology and Drug Discovery, reflecting its impact and reach. Since transitioning to an open access format in 2023, the journal has enhanced accessibility to vital research, empowering a broader audience to contribute to and engage with the discourse surrounding vaccines. As the field of immunization continues to evolve, Expert Review of Vaccines remains a cornerstone for those committed to advancing knowledge and practice in this essential area of health science.